# Polylactide/Polycaprolactone Nanofiber Scaffold Enhances Primary Cortical Neuron Growth

## TL;DR

A new biodegradable scaffold made from polylactide and polycaprolactone improves neuron growth and supports less reactive astrocytes, offering potential for spinal cord injury repair.

## Contribution

A novel solvent system for fabricating nanofiber scaffolds that enhances neuronal integration and modulates glial morphology.

## Key findings

- DCM/THF-based scaffolds increased neuronal density fivefold and maintained 80% viability over 10 days.
- DCM/THF scaffolds supported astrocytes with less reactive morphology compared to HFIP-based scaffolds.
- PLA/PCL scaffolds degraded under oxidative conditions, matching the post-injury microenvironment.

## Abstract

Spinal cord injury (SCI) remains a major clinical challenge due to the limited regenerative capacity of the central nervous system (CNS). Effective scaffolds for repair must combine mechanical compatibility with host tissue, controlled degradation matching the time course of regeneration, and microarchitectural features that promote neuronal survival. Electrospun nanofibrous scaffolds mimic the structural and mechanical features of the extracellular matrix, providing critical cues for neuronal adhesion and glial modulation in neural regeneration. Here, we fabricated biodegradable poly(lactic acid)/poly(ε-caprolactone) (PLA/PCL) scaffolds using a dichloromethane/tetrahydrofuran (DCM/THF) solvent system to induce surface porosity via solvent-driven phase separation. The DCM/THF solvent system formulation produced nanofibers with porous surfaces and increased area for cell interaction. PLA/PCL scaffolds showed a Young’s modulus of ~26 MPa and sustained degradation, particularly under oxidative conditions simulating the post-injury microenvironment. In vitro, these scaffolds enhanced neuronal density up to fivefold and maintained ~80% viability over 10 days in primary neuron–glia cultures. Morphometric analysis revealed that DCM/THF-based scaffolds supported astrocytes with preserved process complexity and reduced circularity, indicative of a less reactive morphology. In contrast, scaffolds fabricated with 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) displayed reduced bioactivity and promoted morphological features associated with astrocyte reactivity, including cell rounding and process retraction. These findings demonstrate that solvent-driven control of scaffold microarchitecture is a powerful strategy to enhance neuronal integration and modulate glial morphology, positioning DCM/THF-processed PLA/PCL scaffolds as a promising platform for CNS tissue engineering.